Latest news
Cytokinetics (CYTK) Stock Looks Near Fair Value Despite UK MYQORZO Approval - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 11:10:15 GMTCytokinetics (CYTK) Stock Sees MYQORZO Momentum Collide With Mounting Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:21:26 GMTCytokinetics’ Myqorzo Launch Is Turning Heads In Cardiology - FinimizeFinimize · Fri, 07 Aug 2026 22:12:36 GMTCYTK Q2 Earnings Top Estimates, Myqorzo Uptake Strong - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 17:55:55 GMTCytokinetics: MYQORZO Net Pdt Rev of $25M >CYTK - MoomooMoomoo · Fri, 07 Aug 2026 13:04:49 GMTHow Investors May Respond To Cytokinetics (CYTK) UK MYQORZO Approval Amid Wider Quarterly Loss - simplywall.stsimplywall.st · Fri, 07 Aug 2026 08:30:16 GMTCytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launch - ChartMillChartMill · Thu, 06 Aug 2026 20:49:51 GMTCytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 20:13:57 GMT